M P8 (Pantoprazole Sodium Delayed Release 20 mg)
Pill with imprint M P8 is Yellow, Elliptical / Oval and has been identified as Pantoprazole Sodium Delayed Release 20 mg. It is supplied by Matrix Laboratories Limited.
Pantoprazole is used in the treatment of barrett's esophagus; dumping syndrome; gerd; duodenal ulcer; erosive esophagitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M P8
Pantoprazole Sodium Delayed Release
- Imprint:
- M P8
- Strength:
- 20 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Matrix Laboratories Limited
- Inactive Ingredients:
- ammonia
ferrosoferric oxide
calcium stearate
crospovidone
hypromelloses
mannitol
methacrylic acid - ethyl acrylate copolymer (1:1) type a
povidone
propylene glycol
sodium carbonate
shellac
titanium dioxide
triethyl citrate
ferric oxide yellow
Note: Inactive ingredients may vary.
More about pantoprazole
- Pantoprazole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 154 Reviews
- Drug class: proton pump inhibitors
Consumer resources
- Pantoprazole
- Pantoprazole Delayed-Release Tablets
- Pantoprazole Delayed-Release Granules
- Pantoprazole Injection
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
Other brands: Protonix, Protonix IV
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
